Director Sandra Peterson reports Seaport Therapeutics (SPTX) stock option holdings
Rhea-AI Filing Summary
Seaport Therapeutics director Sandra E. Peterson reported her initial holdings of stock options in Seaport Therapeutics, Inc. The filing lists two option grants to buy Common Stock: one covering 12,258 underlying shares at an exercise price of $10.31, and another covering 77,042 underlying shares at $7.39.
For the 12,258-share option, one-third of the underlying shares vested on December 2, 2025, with the rest vesting in 24 equal monthly installments, subject to her continued service. The 77,042-share option is scheduled to vest and become exercisable on February 24, 2027, also subject to continued service, with expiration dates in 2036 and 2034 respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
PETERSON SANDRA E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 77,042 shares (Direct)
Footnotes (1)
- 1/3rd of the shares underlying this option vested and became exercisable on December 2, 2025, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The shares underlying this option shall vest and become exercisable on February 24, 2027, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Option underlying shares 1: 12,258 shares
Exercise price 1: $10.31 per share
Option underlying shares 2: 77,042 shares
+4 more
7 metrics
Option underlying shares 1
12,258 shares
Underlying Common Stock for one stock option holding
Exercise price 1
$10.31 per share
Exercise price of 12,258-share stock option
Option underlying shares 2
77,042 shares
Underlying Common Stock for second stock option holding
Exercise price 2
$7.39 per share
Exercise price of 77,042-share stock option
Expiration date 1
February 23, 2036
Expiration of 12,258-share option
Expiration date 2
December 28, 2034
Expiration of 77,042-share option
Initial derivative holdings entries
2 option positions
Holding entries listed in Form 3 transaction summary
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 10.3100 and 7.3900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-02-23T00:00:00.000Z and 2034-12-28T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest financial
"1/3rd of the shares underlying this option vested and became exercisable"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
underlying security financial
"underlying_security_title: Common Stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Sandra E. Peterson’s Form 3 for Seaport Therapeutics (SPTX) show?
The Form 3 shows initial stock option holdings for director Sandra E. Peterson. She holds options over 12,258 shares at $10.31 and 77,042 shares at $7.39, each with specific vesting schedules and long-dated expiration terms.
Are there any stock purchases or sales in Sandra Peterson’s Seaport Therapeutics (SPTX) Form 3?
The filing reports holdings only, with no indicated stock purchases or sales. It lists two stock option positions, their exercise prices, vesting conditions, and expiration dates, serving as a baseline disclosure of her derivative ownership in Seaport Therapeutics.
When do Sandra Peterson’s Seaport Therapeutics stock options expire?
Her 12,258-share option at $10.31 per share expires on February 23, 2036. The 77,042-share option at $7.39 per share expires on December 28, 2034, providing long-term potential exercisability if vesting and service conditions are met.